Viral infections are primarily known for causing acute illnesses, but their impact on human health can extend far beyond the initial recovery period. Clinical observations show that complications from viruses are not limited to immediate illness; they can occasionally present as a delayed or late autoimmune response [1]. Understanding the connection between viral triggers and autoimmunity helps clinicians recognize new symptoms that arise weeks or months after an infection.
A prominent area of study involves immune-mediated thyroid dysfunction following viral exposure. Research indicates that COVID-19 can induce or exacerbate autoimmune disorders, including thyroid conditions like Graves' disease and Hashimoto's thyroiditis [4]. For example, patients with no prior history of thyroid problems have developed hyperthyroidism several weeks after recovering from COVID-19 [2]. Case reports have also documented individuals developing both Graves' disease and skin conditions like psoriasis vulgaris following a SARS-CoV-2 infection [3]. Experts suggest that evaluations for persistent post-viral symptoms should include thorough thyroid assessments [3].
Liver health is another area affected by post-viral immune reactions. Acute viral hepatitis, such as hepatitis A, typically presents as a self-limiting acute icteric syndrome [7]. However, medical literature documents instances where hepatitis A triggers autoimmune hepatitis [5]. Patients recovering from the virus have experienced secondary increases in liver enzymes alongside high serum titers of autoantibodies, such as anti-nuclear antibodies and immunoglobulin G, leading to a dual diagnosis of acute infection and autoimmune hepatitis [5]. Hepatitis A has also been linked to a variety of extra-hepatic manifestations, including systemic and regional autoimmune events [7].
Influenza is another viral pathogen investigated for its role in initiating autoimmune pathways. While influenza is not frequently cited as a primary trigger for chronic autoimmune diseases, published case reports describe autoimmune adverse events following infection [1]. The mechanisms connecting influenza to autoimmunity involve the complex nature of the immune response during infection and its interaction with host tissues [1]. Similarly, studies on COVID-19 have frequently detected diverse autoantibodies—such as antinuclear antibodies, rheumatoid factor, and lupus anticoagulant—in patients following exposure, demonstrating a broad spectrum of post-viral autoimmune reactions [6].
Scientists are actively exploring the biological pathways that allow viruses to provoke the immune system into attacking healthy tissue. Proposed mechanisms include molecular mimicry, where viral peptides share structural similarities with human proteins, causing the immune system to mistakenly target self-antigens [6], [7]. Other potential pathways involve bystander activation driven by hyperinflammatory states, viral persistence, and the formation of neutrophil extracellular traps [6]. These complex processes can lead to symptoms ranging from organ-specific to systemic inflammatory conditions [6]. Recognizing these patterns is essential for managing post-viral complications effectively.
Sources
- 1. Influenza and autoimmunity. (Annals of the New York Academy of Sciences, 2009)
- 2. Thyroid disease post-COVID-19 infection: Report of a case with new-onset autoimmune thyroid disease. (Asia Pacific allergy, 2023)
- 3. Autoimmune Thyroid Disease and Psoriasis Vulgaris after COVID-19 in a Male Teenager. (Case reports in pediatrics, 2021)
- 4. Autoimmune Thyroid Diseases After COVID-19 Infection: A Systematic Review of Clinical Manifestation and Outcomes. (International journal of environmental research and public health, 2026)
- 5. Acute Hepatitis A-Induced Autoimmune Hepatitis: A Case Report and Literature Review. (Medicina, 2022)
- 6. The impact of COVID-19 on autoimmune diseases. (Progress in molecular biology and translational science, 2025)
- 7. Local and systemic autoimmune manifestations linked to hepatitis A infection. (Acta gastro-enterologica Belgica, 2023)
- 8. Beyond Post-tuberculosis Sequelae: Uncovering Common Variable Immunodeficiency in an Adult. (Cureus, 2025)